Nidan Laboratories And Healthcare shareholding pattern

NIDAN

17.5

0.00 (0.00%)
Last updated on 20 Feb, 2026 | 15:20 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Nidan Laboratories And Healthcare Shareholding Pattern

  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

57.04%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

42.96%

Others

0%

Total Promoters
MAR '25
57.04%
SEP '25
57.04%
DEC '25
57.04%

Summary

For Year 2025-26, Nidan Laboratories And Healthcare reports the following shareholding: Total Promoters at 57.04%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 42.96%. This breakdown provides a quick snapshot of ownership distribution for Nidan Laboratories And Healthcare in 2025-26.

Nidan Laboratories And Healthcare FAQs

As of 02-2026, the promoter shareholding in Nidan Laboratories And Healthcare stands at 57.04% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Nidan Laboratories And Healthcare is 0% and 0% respectively.

The retail shareholding of the Nidan Laboratories And Healthcare is 42.96%.

Changes in shareholding patterns of Nidan Laboratories And Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Nidan Laboratories And Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost